Tanmay Kulkarni

Tanmay Kulkarni

Bristol-Myers Squibb Co. - New York / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5466844
-
person_outline Tanmay Kulkarni's MOST POPULAR ARTICLES
1-) A year-long extended release nanoformulated cabotegravir prodrugTA Kulkarni, AN Bade, B Sillman, BLD Shetty, MS Wojtkiewicz, N Gautam, ...Nature materials 19 (8), 910-920, 2020842020
2-) Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravirN Gautam, JEM McMillan, D Kumar, AN Bade, Q Pan, TA Kulkarni, W Li, ...Nature communications 12 (1), 3453, 2021382021
3-) A fully integrated online platform for real time monitoring of multiple product quality attributes in biopharmaceutical processes for monoclonal antibody therapeuticsY Liu, C Zhang, J Chen, J Fernandez, P Vellala, TA Kulkarni, I Aguilar, ...Journal of Pharmaceutical Sciences 111 (2), 358-367, 2022372022
4-) Non-viral vectors for delivery of nucleic acid therapies for cancerS Kanvinde, T Kulkarni, S Deodhar, D Bhattacharya, A DasguptaBioTech 11 (1), 6, 2022262022
5-) The immunopathobiology of SARS-CoV-2 infectionM Patel, F Shahjin, JD Cohen, M Hasan, J Machhi, H Chugh, S Singh, ...FEMS Microbiology Reviews 45 (6), fuab035, 2021162021